Free Trial
NYSE:NKGN

NKGen Biotech (NKGN) Stock Price, News & Analysis

NKGen Biotech logo
$0.19 0.00 (0.00%)
As of 07/25/2025

About NKGen Biotech Stock (NYSE:NKGN)

Key Stats

Today's Range
$0.19
$0.19
50-Day Range
$0.19
$0.38
52-Week Range
$0.10
$1.29
Volume
N/A
Average Volume
1.79 million shs
Market Capitalization
$8.54 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

NKGen Biotech Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
12th Percentile Overall Score

NKGN MarketRank™: 

NKGen Biotech scored higher than 12% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    There is not enough analysis data for NKGen Biotech.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of NKGen Biotech is -0.04, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of NKGen Biotech is -0.04, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Percentage of Shares Shorted

    1.16% of the float of NKGen Biotech has been sold short.
  • Short Interest Ratio / Days to Cover

    NKGen Biotech has a short interest ratio ("days to cover") of 1.5, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in NKGen Biotech has recently increased by 13.98%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    NKGen Biotech does not currently pay a dividend.

  • Dividend Growth

    NKGen Biotech does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    1.16% of the float of NKGen Biotech has been sold short.
  • Short Interest Ratio / Days to Cover

    NKGen Biotech has a short interest ratio ("days to cover") of 1.5, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in NKGen Biotech has recently increased by 13.98%, indicating that investor sentiment is decreasing significantly.
  • News Sentiment

    NKGen Biotech has a news sentiment score of 0.08. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 1.09 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 2 news articles for NKGen Biotech this week, compared to 1 article on an average week.
  • Insider Buying vs. Insider Selling

    In the past three months, NKGen Biotech insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    10.36% of the stock of NKGen Biotech is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    76.17% of the stock of NKGen Biotech is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about NKGen Biotech's insider trading history.
Receive NKGN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for NKGen Biotech and its competitors with MarketBeat's FREE daily newsletter.

NKGN Stock News Headlines

Your $200 account credit is about to expire
Update to MarketBeat All Access and Save $200 on Your Annual Subscription
See More Headlines

NKGN Stock Analysis - Frequently Asked Questions

NKGen Biotech's stock was trading at $0.6552 at the beginning of the year. Since then, NKGN shares have decreased by 71.0% and is now trading at $0.19.

Shares of NKGN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that NKGen Biotech investors own include Meta Platforms (META), IonQ (IONQ), Eli Lilly and Company (LLY), NVIDIA (NVDA), Viking Therapeutics (VKTX), Adaptimmune Therapeutics (ADAP) and C3.ai (AI).

Company Calendar

Today
7/27/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NYSE
Sector
Medical
Industry
Biological products, except diagnostic
Sub-Industry
Pharmaceutical Products
Current Symbol
NYSE:NKGN
Previous Symbol
NYSE:NKGN
CIK
1845459
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($2.45)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$82.94 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
-479.36%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
0.02
Quick Ratio
0.02

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
($2.68) per share
Price / Book
-0.07

Miscellaneous

Outstanding Shares
44,948,000
Free Float
40,291,000
Market Cap
$8.54 million
Optionable
Not Optionable
Beta
1.26
The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.

Get This Free Report

This page (NYSE:NKGN) was last updated on 7/27/2025 by MarketBeat.com Staff
From Our Partners